SOPHARMA AD: Current report 63 buy back 16052013

opublikowano: 2013-05-16 13:58

Spis treści:

1. REPORT

2. INFORMATION ABOUT THE ENTITY

3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY


Spis załączników:
Current_report_63_buy_back_16052013.doc  (REPORT)

POLISH FINANCIAL SUPERVISION AUTHORITY
UNI - EN REPORT No 63 / 2013
Date of issue: 2013-05-16
Short name of the issuer
SOPHARMA AD
Subject
Current report 63 buy back 16052013
Official market - legal basis
Art. 56 ust. 1 pkt 1 Ustawy o ofercie - informacje poufne
Unofficial market - legal basis
Contents of the report:
SOPHARMA AD (the “Company") hereby informs that from 9 May 2013 up to and including 15 May 2013 the Company bought 14244 own shares representing 0.01% of the share capital of the Company, to the total value of BGN 38501.05 on the Bulgarian Stock Exchange. The average price per share was BGN 2.70.

The shares have been bought on the basis of the general meeting resolution No. 7 of 23.06.2010.

The total number of own shares after these transactions is 4128001, representing 3.13% of the share capital of the Company.
Annexes
File Description
Current report 63 buy back 16052013.docCurrent report 63 buy back 16052013.doc Current report 63 buy back 16052013

SOPHARMA AD
(fullname of the issuer)
SOPHARMA AD Farmaceutyczny (far)
(short name of the issuer) (sector according to clasification
of the WSE in Warsow)
1220 Sofia
(post code) (city)
IlienskoShosse 16
(street) (number)
+359 2 813 42 00 +359 2 936 02 86
(phone number) (fax)
(e-mail) (web site)
nd
(NIP) (REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Date Name Position / Function Signature
2013-05-16 Ognian Donev Executive Director